News from renalytixai A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 17, 2019, 07:00 ET RenalytixAI Partners with Capital District Physicians' Health Plan, Inc. on KidneyIntelX™

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Capital District ...


Oct 14, 2019, 08:48 ET Johns Hopkins Director of Nephrology Chirag Parikh Joins RenalytixAI Board

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the appointment ...


Jul 29, 2019, 08:35 ET RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the expansion of its...


Jul 09, 2019, 08:30 ET RenalytixAI Releases Positive Interim Results in Expanded Validation Study for KidneyIntelX™

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today positive...


Jul 01, 2019, 08:30 ET U.S. CPT® Code Granted for KidneyIntelX™

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that the...


Jun 07, 2019, 08:00 ET Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that positive...


May 21, 2019, 08:06 ET RenalytixAI Expands Core Investigator Group for Kidney Transplant Advanced Diagnostic Program

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the expansion...


May 07, 2019, 08:05 ET RenalytixAI and University Medical Center Groningen to Evaluate KidneyIntelX™ for Early Identification and Guiding Therapeutic Treatment of Diabetic Kidney Disease

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today a collaboration ...


May 02, 2019, 08:00 ET FDA Grants Breakthrough Device Designation to KidneyIntelX™

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that it has...


Mar 22, 2019, 08:05 ET RenalytixAI Forms Core Investigator Group for Kidney Transplant Advanced Diagnostic Program

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the formation...


Feb 13, 2019, 07:00 ET RenalytixAI and AKESOgen In Joint Venture Partnership for Expanded Testing Capacity and Pharma Services

RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the completion of a joint...


Feb 06, 2019, 07:00 ET RenalytixAI Expands Leadership Team to Support Launch of AI-Enabled Diagnostics for Kidney Disease

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the expansion of its...


Jan 23, 2019, 08:00 ET RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyIntelX™ for Diagnosing Fast-Progressing Kidney Disease

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the start of its...


Nov 15, 2018, 08:30 ET RenalytixAI Raises $29 Million to Commercialize AI-Enabled Clinical Diagnostic Solutions for Kidney Disease

Renalytix AI plc (LSE AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, has secured $29 million in...